WASHINGTON, D.C. — Today, just before the Memorial Day holiday that has traditionally kicked off the start of the summer beach and pool season, Senators Chris Dodd (D-CT) and Jack Reed (D-RI) sent a letter to U.S. Food and Drug Administration Commissioner Margaret Hamburg inquiring into the delay of a “meaningful, enforceable standard for sunscreen protection that includes both UVA and UVB protection.”
“At long last, the agency made an important step in 2007 when it released the proposed rule for sunscreen products. But too many questions have still not been answered – Why hasn’t the agency finalized this rule? What is the specific timetable for finalizing this rule? How long after the rule is finalized will consumers be able to purchase sunscreen products that meet the new standard for protection? ” Dodd and Reed wrote.
“Millions of Americans purchase and use over-the-counter sunscreen products every year thinking they are being protected from harmful UVA and UVB rays. In the time the agency has been considering a standard for UVA protection in sunscreen, the incidence of skin cancer has been on the rise,” the senators continued. “All Americans deserve equal access to clear, accurate and comprehensive sunscreen labeling, which includes informing them about UVA and UVB protection, as their first line of defense against skin cancer.”
In 2009, Dodd and Reed introduced legislation, the SUN Act, to help Americans better protect themselves from the sun’s harmful rays. The SUN Act would require the Food and Drug Administration (FDA) to strengthen labeling and testing standards for sunscreen products. Currently, FDA standards require that sunscreen protect against UVB rays, known for causing sunburns and increasing the chance of skin cancer. However, they do not require protection against UVA rays, which are a major cause of skin cancer and premature aging.
Dodd and Reed’s full letter to Commissioner Hamburg is below.
May 28, 2010
Margaret A. Hamburg, M.D.
Commissioner
U.S. Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
Dear Dr. Hamburg:
As we head into another summer, we are writing to inquire about the status of the Food and Drug Administration (FDA)’s progress toward finalizing comprehensive labeling for sunscreen products that includes protection from UVA and UVB radiation. It has now been nearly three years since the FDA issued the proposed rule entitled Sunscreen Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph (72 Fed. Reg. 49070) and still Americans lack a meaningful, enforceable standard for sunscreen protection that includes both UVA and UVB protection. This year, there is a new sense of urgency to our inquiry since recent reports found that some sunscreen products may actually speed the onset of skin cancer.
As we have discussed with you on previous occasions, we are deeply concerned with how long it has taken the FDA to finalize a comprehensive standard for labeling, which the agency has reportedly been working on now for more than 30 years. At long last, the agency made an important step in 2007 when it released the proposed rule for sunscreen products. But too many questions have still not been answered – Why hasn’t the agency finalized this rule? What is the specific timetable for finalizing this rule? How long after the rule is finalized will consumers be able to purchase sunscreen products that meet the new standard for protection? Lastly, there has been a lot of attention paid to sunscreen products this week, especially in light of news that the use of vitamin A or its derivatives in sunscreen products may actually speed the onset of cancer. What is the agency doing to inform consumers that the products they are buying may not offer the level of protection advertised in the labeling or marketing materials?
In the past we have been told that a reason for the delay in finalizing the proposed rule is due to the number of written comments the agency received. How many comments did the agency receive? How does that compare to comments received for other proposed rules for over-the-counter products? How does the FDA’s timeline for responding to comments to this proposed rule compare to its response time for other proposed rules?
Millions of Americans purchase and use over-the-counter sunscreen products every year thinking they are being protected from harmful UVA and UVB rays. In the time the agency has been considering a standard for UVA protection in sunscreen, the incidence of skin cancer has been on the rise. In 2010, about 68,720 Americans will be diagnosed with melanoma, the most serious and most common form of skin cancer. This year alone, an estimated 11,590 Americans will die from skin cancer, 8,650 from melanoma and 2,940 from other non-epithelial skin cancers. As we head into Memorial Day weekend, the unofficial start of the summer season, it is even more important that consumers are educated about and protected from UVA rays that are as harmful, if not more harmful, than UVB rays.
All Americans deserve equal access to clear, accurate and comprehensive sunscreen labeling, which includes informing them about UVA and UVB protection, as their first line of defense against skin cancer. We look forward to hearing from you with information about when this proposed rule will be finalized and when consumers will be able to purchase sunscreen products
with the knowledge that they meet FDA’s enforceable standard.
Thank you for your consideration and we look forward to your reply.
Sincerely,
Christopher J. Dodd
United States Senator
Jack Reed
United States Senator






